
Barbara P. Badio
Examiner (ID: 19223, Phone: (571)272-0609 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1201, 1628, 1616, 1612, 1209, 2899, 1617, 1621 |
| Total Applications | 2277 |
| Issued Applications | 1268 |
| Pending Applications | 157 |
| Abandoned Applications | 857 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16007375
[patent_doc_number] => 20200178530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CRYSTALLINE FORM C OF SHUANGZUOCAOTONG, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/629879
[patent_app_country] => US
[patent_app_date] => 2017-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629879 | Crystalline form C of shuangzuocaotong, preparation method therefor and use thereof | Jul 14, 2017 | Issued |
Array
(
[id] => 14883491
[patent_doc_number] => 10421772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Steroids as agonists for FXR
[patent_app_type] => utility
[patent_app_number] => 15/645136
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645136 | Steroids as agonists for FXR | Jul 9, 2017 | Issued |
Array
(
[id] => 14883491
[patent_doc_number] => 10421772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Steroids as agonists for FXR
[patent_app_type] => utility
[patent_app_number] => 15/645136
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4197
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645136
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645136 | Steroids as agonists for FXR | Jul 9, 2017 | Issued |
Array
(
[id] => 14962921
[patent_doc_number] => 20190308938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => Heterocyclic Compounds for the Treatment of Arenavirus
[patent_app_type] => utility
[patent_app_number] => 16/309858
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309858 | Heterocyclic compounds for the treatment of arenavirus | Jul 6, 2017 | Issued |
Array
(
[id] => 11977496
[patent_doc_number] => 20170281651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A OR STEROIDOGENESIS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/627368
[patent_app_country] => US
[patent_app_date] => 2017-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 36541
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15627368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/627368 | CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A OR STEROIDOGENESIS INHIBITORS | Jun 18, 2017 | Abandoned |
Array
(
[id] => 16999439
[patent_doc_number] => 11078230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/622568
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 139
[patent_figures_cnt] => 139
[patent_no_of_words] => 51131
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15622568
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/622568 | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof | Jun 13, 2017 | Issued |
Array
(
[id] => 12979690
[patent_doc_number] => 20170342101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => SYNTHETIC BILE ACID COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/618092
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15618092
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/618092 | Synthetic bile acid compositions and methods | Jun 7, 2017 | Issued |
Array
(
[id] => 12092454
[patent_doc_number] => 20170349547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'CONDUCTING REACTIONS IN LEIDENFROST-LEVITATED DROPLETS'
[patent_app_type] => utility
[patent_app_number] => 15/613520
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7176
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613520
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613520 | Conducting reactions in Leidenfrost-levitated droplets | Jun 4, 2017 | Issued |
Array
(
[id] => 14258867
[patent_doc_number] => 10278977
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Methods for treating hypersomnolence
[patent_app_type] => utility
[patent_app_number] => 15/613539
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5998
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613539
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/613539 | Methods for treating hypersomnolence | Jun 4, 2017 | Issued |
Array
(
[id] => 13593347
[patent_doc_number] => 20180348222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => BUFADIENOLIDE FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 15/610709
[patent_app_country] => US
[patent_app_date] => 2017-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15610709
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/610709 | BUFADIENOLIDE FOR TREATMENT OF NON-SMALL CELL LUNG CANCER | May 31, 2017 | Abandoned |
Array
(
[id] => 12030807
[patent_doc_number] => 20170320905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHODS FOR THE PURIFICATION OF DEOXYCHOLIC ACID'
[patent_app_type] => utility
[patent_app_number] => 15/603290
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 34231
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603290 | Methods for the purification of deoxycholic acid | May 22, 2017 | Issued |
Array
(
[id] => 13689423
[patent_doc_number] => 20170355666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => POLYMORPHS OF CDDO ETHYL ESTER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/601968
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601968
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601968 | POLYMORPHS OF CDDO ETHYL ESTER AND USES THEREOF | May 21, 2017 | Abandoned |
Array
(
[id] => 16229377
[patent_doc_number] => 10736907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Use of sugar-alcohols in tibolone compositions
[patent_app_type] => utility
[patent_app_number] => 16/095917
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7825
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095917
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095917 | Use of sugar-alcohols in tibolone compositions | May 3, 2017 | Issued |
Array
(
[id] => 13702633
[patent_doc_number] => 20170362271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/586710
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586710
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586710 | Certain steroids and methods for using the same in the treatment of cancer | May 3, 2017 | Issued |
Array
(
[id] => 14130085
[patent_doc_number] => 20190099432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF CHRONIC VULVAL AND PERINEAL PAIN AND SYMPTOMS AND CONDITIONS ASSOCIATED THEREWITH
[patent_app_type] => utility
[patent_app_number] => 16/098428
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098428
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098428 | Compositions for the treatment of chronic vulval and perineal pain and symptoms and conditions associated therewith | Apr 30, 2017 | Issued |
Array
(
[id] => 11851656
[patent_doc_number] => 20170226148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 15/496160
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/496160 | 3-(4'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE | Apr 24, 2017 | Abandoned |
Array
(
[id] => 14336923
[patent_doc_number] => 20190150434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHOD FOR ENHANCING PLANT DISEASE CONTROLLING EFFECTS OF ARYL PHENYL KETONE FUNGICIDE, AND METHOD FOR CONTROLLING PLANT DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/092579
[patent_app_country] => US
[patent_app_date] => 2017-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092579 | Method for enhancing plant disease controlling effects of aryl phenyl ketone fungicide, and method for controlling plant diseases | Apr 12, 2017 | Issued |
Array
(
[id] => 12138213
[patent_doc_number] => 20180016295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'TGR5 Modulators and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/482107
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 47912
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482107
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/482107 | TGR5 Modulators and Methods of Use Thereof | Apr 6, 2017 | Abandoned |
Array
(
[id] => 11821839
[patent_doc_number] => 20170210776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'CATIONIC STEROIDAL ANTIMICROBIALS'
[patent_app_type] => utility
[patent_app_number] => 15/481884
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17635
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481884
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481884 | Cationic steroidal antimicrobials | Apr 6, 2017 | Issued |
Array
(
[id] => 14069215
[patent_doc_number] => 20190083495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Methods Of Preventing Or Reducing A Fibrotic Response Using CSF1R Inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/081654
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081654 | Methods Of Preventing Or Reducing A Fibrotic Response Using CSF1R Inhibitors | Apr 3, 2017 | Abandoned |